// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

HEMATOLOGICAL ABNORMALITIES IN 624 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THEIR RELATIONSHIP WITH ORGAN INVOLVEMENT

A. Alarfaj - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

CLINICAL PRESENTATION, TREATMENT AND OUTCOME OF MEMBRANOUS NEPHROPATHY IN SLE: A COMPARISON WITH PROLIFERATIVE LUPUS GLOMERULONEPHRITIS IN 141 PATIENTS

C.C. Mok - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Mycophenolate mofetil

HYDROXYCHLOROQUINE REDUCES THROMBOSIS (BOTH ARTERIAL AND VENOUS) IN SYSTEMIC LUPUS ERYTHEMATOSUS, PARTICULARLY IN ANTIPHOSPHOLIPID POSITIVE PATIENTS

G. Law - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Hydroxychloroquine

VALVULAR HEART DISEASE IN ANTIPHOSPHOLIPID SYNDROME

V. Saurit - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

THE LEVELS OF PLASMINOGEN AND PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME

T.M. Reshetnyak - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

IS THERE ANY NAILFOLD CAPILLAROSCOPIC PATTERN IN PATIENTS WITH PRIMARY Sjogren's Syndrome WITH OR WITHOUT RAYNAU-S PHENOMENON AND/OR POSITIVE ANTI-RO/ANTI-LA?

V. Ortiz-Santamaria - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

MORPHOFUNCTIONAL PENILE ALTERATIONS WITH SEVERE SPERM ABNORMALITIES IN ANTIPHOSPHOLIPID SYNDROME ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS

C.N. Rabelo-Junior - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Cyclophosphamide

PROFILING OF ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATION WITH CLINICAL SYMPTOMS IN FOLLOW-UP SAMPLES OF APS PATIENTS

D. Roggenbuck - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Phosphatidylinositol

ARTERIAL APS (AAPS): CLINICAL AND LABORATORY FINDINGS IN A COHORT OF 28 PATIENTS

A. Kuzenko - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

FVIII

THE UTILITY OF IGA ANTIPHOSPHOLIPID ANTIBODIES FOR PREDICTION OF THROMBOTIC COMPLICATIONS IN SECONDARY ANTIPHOSPHOLIPID SYNDROME

T.A. Iwaniec - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

FLUVASTATIN TREATMENT PREVENTS THE INFLAMMATORY/OXIDATIVE STATUS LINKED TO THE CLINICAL ACTIVITY OF THE DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

P. Ruiz-Limon - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Fluvastatin

ANTIBODIES AGAINST OXIDIZED BUT NOT NON-OXIDIZED CARDIOLIPIN AND PHOSPHATYLSERINE HAVE ATHEROPROTECTIVE PROPERTIES IN SLE

J. Frostegard - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Phosphatidylserine

ANTIBODIES VERSUS DOMAIN I OF BETA2-GLYCOPROTEIN I: A MARKER OF SYSTEMIC AUTOIMMUNITY?

C. Nalli - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

IMMUNODOT ASSAY OF IGG AND IGM ANTIBODIES TO PHOSPOLIPIDS AND ?2-GLYCOPROTEIN I IN PATIENTS WITH ARTERIAL AND VENOUS THROMBOSIS

N.A. Bashlakova - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Phosphatidylserine

VITAMIN D AND CARDIOVASCULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS

O.A. Monticielo - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Hydroxychloroquine

MICROPARTICLES IN HAEMOSTASIS AND THROMBOSIS

N. Mackman - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Phosphatidylserine

TWO DIFFICULT SLE PATIENT CASES

R. Derksen - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Prednisone

POPULATION-BASED EPIDEMIOLOGY AND DESCRIPTION OF BEHCE-S DISEASE IN THE AFRICAN DESCENT POPULATION OF MARTINIQUE, FRENCH WEST INDIES

C. Deligny - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Venous thrombosis

Mofezolac

NAILFOLD VIDEOCAPILLAROSCOPY IN PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS (WEGENE-S): AN OBSERVATIONAL STUDY

J. Uceda - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

TAKAYAS-S ARTERITIS IN PREGNANCY: A BRITISH CASE SERIES

P. Mehta - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Oraprine

Copyright © 2026. QuantiNova All rights reserved